查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2046573

螢光原位雜合反應探針市場－全球產業規模、佔有率、趨勢、機會和預測：按技術、類型、應用、最終用途、地區和競爭格局分類，2021-2031年

Fluorescent In Situ Hybridization Probe Market - Global Industry Size, Share, Trends, Opportunity & Forecast, Segmented By Technology, By Type (DNA, RNA ), By Application, By End-Use, By Region & Competition, 2021-2031F
出版日期: | 出版商: TechSci Research | 英文 185 Pages | 商品交期: 2-3個工作天內

價格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

簡介目錄

全球螢光原位雜合反應(FISH) 探針市場預計將從 2025 年的 11.1 億美元大幅成長至 2031 年的 16.7 億美元，複合年成長率為 7.04%。

螢光原位雜合技術（FISH）探針是一種專門的細胞遺傳學檢測儀器，利用螢光基因標記來識別和區分染色體上的特定DNA序列。該市場的主要成長要素是全球癌症和各種遺傳異常等疾病發生率的不斷上升。這些疾病需要精準的分子診斷工具來指南個人化治療方案。日益加重的疾病負擔直接刺激了對細胞遺傳學檢測和先進基因組分析的需求。例如，美國癌症協會預測，到2025年，美國將新增約2,041,910例癌症病例，凸顯了精準診斷介入的迫切需求。 FISH探針在臨床實踐中用於診斷和分析骨髓惡性腫瘤和固態腫瘤的日益普及，也為市場發展提供了助力。另一方面，螢光顯微鏡基礎設施的高昂營運成本和複雜的檢測流程是市場成長的主要障礙。結果解讀需要訓練有素的人員，而成像設備的巨額投資限制了其在資源匱乏環境中的應用。因此，FISH 檢測可能不會像更經濟實惠的診斷方法那樣普及。

市場概覽
預測期 2027-2031
市場規模：2025年 11.1億美元
市場規模：2031年 16.7億美元
複合年成長率：2026-2031年 7.04%
成長最快的細分市場 癌症調查
最大的市場 北美洲

市場促進因素

全球螢光原位雜合反應(FISH) 探針市場的主要驅動力是精準醫療和伴隨診斷的快速發展。隨著臨床醫生越來越傾向於使用需要特定生物標記進行患者篩選的標靶治療，用於識別 HER2 擴增和 ALK 重排等基因異常的 FISH 探針的需求顯著成長。這一趨勢鞏固了細胞遺傳學分析在腫瘤學領域的重要性，因為精準的分子譜分析對於有效治療至關重要。例如，根據精準醫療聯盟於 2025 年 5 月發布的報告《FDA 的精準醫療：2024 年進展的範圍和意義》，2024 年將有 18 種新的精準藥物獲得 FDA核准，約佔所有新治療分子實體的 38%。這凸顯了現代藥物療法對強大的診斷工具進行精準患者分層的依賴。此外，多重檢測技術和自動化 FISH 系統的進步正在克服人工分析的局限性，並革新檢查室操作。探針製造商正在開發預先最佳化的自動化檢測組合，這些組合能夠顯著縮短檢測週期並提高信噪比，從而增強繁忙的病理檢查室的診斷能力。例如，2025年4月，Empire Genomics推出了其首個用於自動化平台CellWriter S的預最佳化血液學FISH探針組合，以簡化檢測流程。正如行業領導者的財務成功所表明的那樣，此類創新對於市場的持續成長至關重要。 Revvity公佈其2024會計年度診斷業務收入達15億美元，反映出商業性對先進診斷解決方案的穩定需求。

市場挑戰

由於營運成本高且調查方法密集，螢光原位雜合反應(FISH) 探針的全球市場面臨許多限制因素。 FISH 分析需要對先進的螢光顯微鏡設備進行大量資本投入，並依賴對精度要求極高的複雜操作流程。這種巨大的經濟和技術負擔構成了主要障礙，限制了 FISH 檢測的應用，使其僅限於資金雄厚的參考檢查室和大型學術機構。因此，小規模、資源有限的地區醫院和醫療機構往往難以證明這項投資的合理性，這直接縮小了潛在基本客群，並阻礙了這些診斷工具的廣泛商業性應用。此外，熟練複雜基因組數據解讀技能的技術人員嚴重短缺，進一步加劇了這些挑戰。這種專業知識的匱乏造成了營運瓶頸，導致回應時間延長和檢測能力下降。美國臨床病理學會 (ASCP) 報告稱，到 2025 年，解剖病理科的空缺率將達到 28.5%，凸顯了固態腫瘤分析和高級診斷所需專家的嚴重短缺。這種短缺迫使許多醫療機構選擇勞動強度較低的替代診斷技術，這直接阻礙了 FISH 探針市場檢測量和產生收入潛力的成長。

市場趨勢

由於RNA-FISH技術在空間轉錄組學和單細胞分析領域的快速發展，市場正經歷重大變革。這使其效用超越了傳統的以DNA為中心的應用，能夠可視化組織結構內的基因表現。這一趨勢的驅動力在於人們對理解腫瘤微環境和細胞異質性的需求日益成長，而基於RNA的探針則有助於在細胞內層級繪製轉錄分佈圖。這種發展帶來的商業性影響體現在空間生物學試劑消耗量的增加，這些試劑正逐漸成為探針製造商穩定的收入來源。例如，根據10x Genomics公司於2025年1月發布的“2024會計年度第四季及全年初步快報”，該公司2024會計年度空間生物學耗材的累計約為1.211億美元，凸顯了這些先進的原位雜合反應平台在生命科學研究中的持續大規模應用。同時，FISH檢測與次世代定序（NGS）平台的整合代表診斷調查方法的重大進步，建構了一種全面的基因組分析方法。 NGS提供高通量定序分析，而FISH對於確認結構突變和識別僅靠定序可能遺漏的易位至關重要，這促使實驗室擴大採用聯合檢測模式。這種互補方法確保了對具有臨床意義的生物標記的可靠檢測，並維持了對細胞遺傳學檢測服務以及分子定序的需求。在2025年2月發布的2024會計年度第四季及全年財務業績報告中，NeoGenomics公佈2024會計年度營收為6.61億美元。這一業績得益於該公司廣泛的腫瘤檢測產品組合的強勁成長，該產品組合涵蓋細胞遺傳學檢測和先進的分子技術。

目錄

第1章概述

第2章：調查方法

第3章執行摘要

第4章：客戶心聲

第5章：全球螢光雜合反應探針市場展望

  • 市場規模及預測
    • 按金額
  • 市佔率及預測
    • 依技術分類（Q-FISH、FLOW-FISH 等）
    • 按類型（DNA、RNA（mRNA、miRNA、其他））
    • 按應用領域（癌症研究、遺傳疾病、其他）
    • 依最終用途（研究、臨床、伴隨診斷）
    • 按地區
    • 按公司（2025 年）
  • 市場地圖

第6章：北美螢光雜合反應探針市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 北美洲：國別分析
    • 美國
    • 加拿大
    • 墨西哥

第7章：歐洲螢光雜合反應探針市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 歐洲：國別分析
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙

第8章：亞太地區螢光雜合反應雜交探針市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 亞太地區：國別分析
    • 中國
    • 印度
    • 日本
    • 韓國
    • 澳洲

第9章：中東和非洲螢光雜合反應雜交探針市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 中東與非洲：國別分析
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 南非

第10章：南美洲螢光原位雜合反應探針市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 南美洲：國別分析
    • 巴西
    • 哥倫比亞
    • 阿根廷

第11章 市場動態

  • 促進因素
  • 任務

第12章 市場趨勢與發展

  • 併購
  • 產品發布
  • 近期趨勢

第13章 全球螢光雜合反應探針市場：SWOT分析

第14章：波特五力分析

  • 產業競爭
  • 新進入者的潛力
  • 供應商的議價能力
  • 顧客權力
  • 替代品的威脅

第15章 競爭格局

  • Thermo Fisher Scientific Inc.
  • PerkinElmer Health Sciences Inc
  • Biodot Inc
  • New Horizons Diagnostic Corp
  • Merck KGaA
  • Agilent Technologies, Inc.
  • Abnova Corp.
  • Genemed Biotechnologies Inc
  • F. Hoffmann-La Roche Ltd
  • Oxford Gene Technology Ltd

第16章 策略建議

第17章：關於研究公司及免責聲明

簡介目錄
Product Code: 16616

The global market for Fluorescent In Situ Hybridization (FISH) probes is projected to expand significantly, rising from USD 1.11 billion in 2025 to USD 1.67 billion by 2031, demonstrating a Compound Annual Growth Rate (CAGR) of 7.04%. FISH probes are specialized cytogenetic instruments employed to identify and pinpoint specific DNA sequences on chromosomes through the use of fluorescent genetic markers. This market's primary growth impetus stems from the increasing worldwide incidence of diseases like cancer and various genetic abnormalities, which demand precise molecular diagnostic tools to inform personalized treatment approaches. This growing disease burden directly stimulates the need for cytogenetic testing and advanced genomic analysis. For instance, the American Cancer Society anticipates approximately 2,041,910 new cancer diagnoses in the United States in 2025, underscoring the critical requirement for accurate diagnostic interventions. The market also benefits from the expanding adoption of FISH probes within clinical settings for the diagnosis and profiling of hematological malignancies and solid tumors. Conversely, a significant hurdle to market growth is the considerable operational expenses tied to fluorescence microscopy infrastructure and the intricate nature of the testing protocols. The necessity for highly trained personnel to interpret results, combined with the substantial capital outlay for imaging equipment, can restrict access in settings with limited resources, thereby hindering the widespread acceptance of FISH testing when compared to more affordable diagnostic alternatives.

Market Overview
Forecast Period2027-2031
Market Size 2025USD 1.11 Billion
Market Size 2031USD 1.67 Billion
CAGR 2026-20317.04%
Fastest Growing SegmentCancer Research
Largest MarketNorth America

Market Driver

The primary impetus for the global Fluorescent In Situ Hybridization Probe market is the rapid rise of personalized medicine and companion diagnostics. With clinicians increasingly favoring targeted therapies that necessitate specific biomarkers for patient selection, the demand for FISH probes-used to identify genetic anomalies such as HER2 amplification or ALK rearrangements-has seen a considerable increase. This trend solidifies the importance of cytogenetic analysis in oncology, where accurate molecular profiling is essential for effective treatment. For example, the 'Personalized Medicine at FDA: The Scope & Significance of Progress in 2024' report by the Personalized Medicine Coalition, published in May 2025, indicated that 18 new personalized medicines were FDA-approved in 2024, representing about 38% of all new therapeutic molecular entities. This highlights modern pharmacotherapy's reliance on strong diagnostic tools for precise patient stratification. Concurrent technological advancements in multiplexing and automated FISH systems are transforming laboratory operations by alleviating the constraints of manual analysis. Probe manufacturers are creating pre-optimized and automated panels that substantially reduce turnaround times and improve signal-to-noise ratios, thereby boosting diagnostic capacity in busy pathology labs. Empire Genomics, for instance, introduced the first pre-optimized hematology FISH probe panels for its CellWriter S automated platform in April 2025, aiming to streamline testing. These innovations are vital for sustained market growth, as demonstrated by the financial success of leading industry players; Revvity reported a $1.5 billion revenue for its Diagnostics segment in fiscal year 2024, reflecting consistent commercial demand for advanced diagnostic solutions.

Market Challenge

The global market for Fluorescent In Situ Hybridization (FISH) probes faces considerable limitations due to the elevated operational costs and the resource-intensive characteristics of its testing methodologies. Performing FISH analysis necessitates a substantial capital outlay for sophisticated fluorescence microscopy equipment and depends on intricate protocols that demand exceptional precision. This significant financial and technical load acts as a formidable barrier, largely restricting the adoption of FISH testing to adequately funded reference laboratories and major academic institutions. As a result, smaller community hospitals and healthcare facilities with limited resources frequently cannot justify the investment, which directly curtails the potential customer base and impedes the widespread commercial uptake of these diagnostic instruments. Adding to these difficulties, a severe scarcity of specialized laboratory professionals skilled in interpreting complex genomic data further exacerbates the challenge. This shortage of expert personnel creates operational bottlenecks, contributing to extended turnaround times and diminished testing capabilities. The American Society for Clinical Pathology reported a 28.5% vacancy rate in anatomic pathology departments in 2025, underscoring a critical lack of the specialized workforce essential for solid tumor profiling and advanced diagnostics. This gap compels numerous healthcare providers to opt for alternative, less labor-intensive diagnostic techniques, directly hindering the volume growth and revenue generation potential of the FISH probe market.

Market Trends

A significant market transformation is underway with the swift growth of RNA FISH in spatial transcriptomics and single-cell analysis, extending its utility beyond traditional DNA-focused applications to enable the visualization of gene expression within tissue structures. This trend is fueled by the escalating demand to comprehend the tumor microenvironment and cellular heterogeneity, where RNA-based probes facilitate mapping transcript distribution at a subcellular level. The commercial ramifications of this evolution are apparent in the rising consumption of spatial biology reagents, which are evolving into a steady revenue source for probe producers. For instance, 10x Genomics' 'Preliminary Select Fourth Quarter and Full Year 2024 Results' report from January 2025 indicated that the company generated approximately $121.1 million in spatial consumables revenue for fiscal year 2024, underscoring the substantial and continuous use of these advanced in situ hybridization platforms in life science research. Concurrently, the integration of FISH assays with Next-Generation Sequencing (NGS) platforms marks a crucial advancement in diagnostic methodologies, creating a holistic approach to genomic profiling. Although NGS provides high-throughput sequence analysis, FISH remains essential for confirming structural variations and identifying translocations that sequencing might overlook, prompting laboratories to increasingly adopt combined testing models. This complementary approach ensures reliable detection of clinically significant biomarkers, thereby sustaining the demand for cytogenetic testing services alongside molecular sequencing. NeoGenomics, as reported in its 'Fourth Quarter and Full Year 2024 Results' in February 2025, achieved $661 million in full-year 2024 revenue, a performance attributed to robust volume growth across its extensive oncology testing portfolio that incorporates both cytogenetic and advanced molecular techniques.

Key Market Players

  • Thermo Fisher Scientific Inc.
  • PerkinElmer Health Sciences Inc
  • Biodot Inc
  • New Horizons Diagnostic Corp
  • Merck KGaA
  • Agilent Technologies, Inc.
  • Abnova Corp.
  • Genemed Biotechnologies Inc
  • F. Hoffmann-La Roche Ltd
  • Oxford Gene Technology Ltd

Report Scope

In this report, the Global Fluorescent In Situ Hybridization Probe Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Fluorescent In Situ Hybridization Probe Market, By Technology

  • Q FISH
  • FLOW FISH
  • Others

Fluorescent In Situ Hybridization Probe Market, By Type

  • DNA
  • RNA

Fluorescent In Situ Hybridization Probe Market, By Application

  • Cancer Research
  • Genetic Diseases
  • Others

Fluorescent In Situ Hybridization Probe Market, By End-Use

  • Research
  • Clinical
  • Companion Diagnostics

Fluorescent In Situ Hybridization Probe Market, By Region

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • France
    • United Kingdom
    • Italy
    • Germany
    • Spain
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Fluorescent In Situ Hybridization Probe Market.

Available Customizations:

Global Fluorescent In Situ Hybridization Probe Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Fluorescent In Situ Hybridization Probe Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Technology (Q FISH, FLOW FISH, Others)
    • 5.2.2. By Type (DNA, RNA (mRNA, miRNA, Others))
    • 5.2.3. By Application (Cancer Research, Genetic Diseases, Others)
    • 5.2.4. By End-Use (Research, Clinical, Companion Diagnostics)
    • 5.2.5. By Region
    • 5.2.6. By Company (2025)
  • 5.3. Market Map

6. North America Fluorescent In Situ Hybridization Probe Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Technology
    • 6.2.2. By Type
    • 6.2.3. By Application
    • 6.2.4. By End-Use
    • 6.2.5. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States Fluorescent In Situ Hybridization Probe Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Technology
        • 6.3.1.2.2. By Type
        • 6.3.1.2.3. By Application
        • 6.3.1.2.4. By End-Use
    • 6.3.2. Canada Fluorescent In Situ Hybridization Probe Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Technology
        • 6.3.2.2.2. By Type
        • 6.3.2.2.3. By Application
        • 6.3.2.2.4. By End-Use
    • 6.3.3. Mexico Fluorescent In Situ Hybridization Probe Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Technology
        • 6.3.3.2.2. By Type
        • 6.3.3.2.3. By Application
        • 6.3.3.2.4. By End-Use

7. Europe Fluorescent In Situ Hybridization Probe Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Technology
    • 7.2.2. By Type
    • 7.2.3. By Application
    • 7.2.4. By End-Use
    • 7.2.5. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. Germany Fluorescent In Situ Hybridization Probe Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Technology
        • 7.3.1.2.2. By Type
        • 7.3.1.2.3. By Application
        • 7.3.1.2.4. By End-Use
    • 7.3.2. France Fluorescent In Situ Hybridization Probe Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Technology
        • 7.3.2.2.2. By Type
        • 7.3.2.2.3. By Application
        • 7.3.2.2.4. By End-Use
    • 7.3.3. United Kingdom Fluorescent In Situ Hybridization Probe Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Technology
        • 7.3.3.2.2. By Type
        • 7.3.3.2.3. By Application
        • 7.3.3.2.4. By End-Use
    • 7.3.4. Italy Fluorescent In Situ Hybridization Probe Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Technology
        • 7.3.4.2.2. By Type
        • 7.3.4.2.3. By Application
        • 7.3.4.2.4. By End-Use
    • 7.3.5. Spain Fluorescent In Situ Hybridization Probe Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Technology
        • 7.3.5.2.2. By Type
        • 7.3.5.2.3. By Application
        • 7.3.5.2.4. By End-Use

8. Asia Pacific Fluorescent In Situ Hybridization Probe Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Technology
    • 8.2.2. By Type
    • 8.2.3. By Application
    • 8.2.4. By End-Use
    • 8.2.5. By Country
  • 8.3. Asia Pacific: Country Analysis
    • 8.3.1. China Fluorescent In Situ Hybridization Probe Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Technology
        • 8.3.1.2.2. By Type
        • 8.3.1.2.3. By Application
        • 8.3.1.2.4. By End-Use
    • 8.3.2. India Fluorescent In Situ Hybridization Probe Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Technology
        • 8.3.2.2.2. By Type
        • 8.3.2.2.3. By Application
        • 8.3.2.2.4. By End-Use
    • 8.3.3. Japan Fluorescent In Situ Hybridization Probe Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Technology
        • 8.3.3.2.2. By Type
        • 8.3.3.2.3. By Application
        • 8.3.3.2.4. By End-Use
    • 8.3.4. South Korea Fluorescent In Situ Hybridization Probe Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Technology
        • 8.3.4.2.2. By Type
        • 8.3.4.2.3. By Application
        • 8.3.4.2.4. By End-Use
    • 8.3.5. Australia Fluorescent In Situ Hybridization Probe Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Technology
        • 8.3.5.2.2. By Type
        • 8.3.5.2.3. By Application
        • 8.3.5.2.4. By End-Use

9. Middle East & Africa Fluorescent In Situ Hybridization Probe Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Technology
    • 9.2.2. By Type
    • 9.2.3. By Application
    • 9.2.4. By End-Use
    • 9.2.5. By Country
  • 9.3. Middle East & Africa: Country Analysis
    • 9.3.1. Saudi Arabia Fluorescent In Situ Hybridization Probe Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Technology
        • 9.3.1.2.2. By Type
        • 9.3.1.2.3. By Application
        • 9.3.1.2.4. By End-Use
    • 9.3.2. UAE Fluorescent In Situ Hybridization Probe Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Technology
        • 9.3.2.2.2. By Type
        • 9.3.2.2.3. By Application
        • 9.3.2.2.4. By End-Use
    • 9.3.3. South Africa Fluorescent In Situ Hybridization Probe Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Technology
        • 9.3.3.2.2. By Type
        • 9.3.3.2.3. By Application
        • 9.3.3.2.4. By End-Use

10. South America Fluorescent In Situ Hybridization Probe Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Technology
    • 10.2.2. By Type
    • 10.2.3. By Application
    • 10.2.4. By End-Use
    • 10.2.5. By Country
  • 10.3. South America: Country Analysis
    • 10.3.1. Brazil Fluorescent In Situ Hybridization Probe Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Technology
        • 10.3.1.2.2. By Type
        • 10.3.1.2.3. By Application
        • 10.3.1.2.4. By End-Use
    • 10.3.2. Colombia Fluorescent In Situ Hybridization Probe Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Technology
        • 10.3.2.2.2. By Type
        • 10.3.2.2.3. By Application
        • 10.3.2.2.4. By End-Use
    • 10.3.3. Argentina Fluorescent In Situ Hybridization Probe Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Technology
        • 10.3.3.2.2. By Type
        • 10.3.3.2.3. By Application
        • 10.3.3.2.4. By End-Use

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Merger & Acquisition (If Any)
  • 12.2. Product Launches (If Any)
  • 12.3. Recent Developments

13. Global Fluorescent In Situ Hybridization Probe Market: SWOT Analysis

14. Porter's Five Forces Analysis

  • 14.1. Competition in the Industry
  • 14.2. Potential of New Entrants
  • 14.3. Power of Suppliers
  • 14.4. Power of Customers
  • 14.5. Threat of Substitute Products

15. Competitive Landscape

  • 15.1. Thermo Fisher Scientific Inc.
    • 15.1.1. Business Overview
    • 15.1.2. Products & Services
    • 15.1.3. Recent Developments
    • 15.1.4. Key Personnel
    • 15.1.5. SWOT Analysis
  • 15.2. PerkinElmer Health Sciences Inc
  • 15.3. Biodot Inc
  • 15.4. New Horizons Diagnostic Corp
  • 15.5. Merck KGaA
  • 15.6. Agilent Technologies, Inc.
  • 15.7. Abnova Corp.
  • 15.8. Genemed Biotechnologies Inc
  • 15.9. F. Hoffmann-La Roche Ltd
  • 15.10. Oxford Gene Technology Ltd

16. Strategic Recommendations

17. About Us & Disclaimer